Translating cutting edge research into a new generation of diagnostics.

Our Molecular Light Technology (MLT) facilitates higher analytical sensitivity, better precision and wider working ranges than other assay systems and has found wide acceptance in clinical and research laboratories across the globe. Based on chemiluminescent (light-emitting) ‘acridinium ester’ compounds, MLT was invented at Cardiff University Medical School and pioneered by Prof. Stuart Woodhead and Prof. Ian Weeks. The invention and translation of the technology achieved a Queen’s Anniversary Prize, the US National Medal of Technology and recognition as “one of the top 100 life changing discoveries” arising from UK universities.

In 2021 we successfully patented a next-generation technology that, for the first time, delivers the benefits of MLT in a miniaturised, portable format. We are now bringing to market an extremely sensitive and accurate handheld diagnostic device which enables lab-accurate diagnostic tests to be performed in just a few minutes at the point of care.

Our multidisciplinary team of industry professionals, scientists and engineers combine commercial experience with specialist expertise in the development and manufacture of high sensitivity in-vitro diagnostics. We have previously built, grown and exited successful medical diagnostic companies and are now concentrating on a new generation of rapid diagnostic tests that will work better for patients and for healthcare practitioners.